Výsledky vyhledávání - "T. Dvoryakovskaya"

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

COVID-19-associated secondary hemophagocytic lymphohistiocytosis (cytokine storm syndrome)

Autor: T. Dvoryakovskaya, Ilia Y. Shilkrot, Rustem F. Tepaev, Ekaterina I. Alekseeva, I. Kriulin, Aleksander G. Surkov

Publikováno v: Annals of the Russian academy of medical sciences. 76:51-66

In most cases, COVID-19 has a favorable outcome. However, the risk of developing critical forms of the disease, including secondary hemophagocytic lymphohistiocytosis HLH (cytokine storm syndrome), remains high. This dictates the interest in studying

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3e91d717729cde25e390dd504c828bfe
https://doi.org/10.15690/vramn1410

Zobrazit plný text záznamu

Efficacy and safety of adalimumab as the first- and second-line biologic therapy for children with juvenile idiopathic arthritis under four years of age

Autor: Rina Denisova, T. Dvoryakovskaya, Alexandra Chomahidze, A. Fetisova, Alina Alshevskaya, A. Mamutova, Ekaterina Alexeeva, T. Sleptsova, Andrey Moskalev, K. Isaeva

Publikováno v: Egyptian Rheumatologist, Vol 42, Iss 3, Pp 231-236 (2020)

Background New biologics developed to treat juvenile idiopathic arthritis (JIA) and the broadening range of indications for young children offer new drug switch options if the first-line treatment has proved ineffective. Nevertheless, the question re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e8d6f20800f79a26be3113ba41efd69
http://www.sciencedirect.com/science/article/pii/S111011642030034X

Zobrazit plný text záznamu

Activity of systemic juvenile idiopathic arthritis in children immunized with pneumococcal 13-valent conjugate vaccine: prospective cohort study

Autor: Ya.O. Orlova, Rina Denisova, E.A. Brzhozovskaya, O. Lomakina, N. E. Tkachenko, О.P. Galkina, I. Zubkova, E.I. Alekseeva, T. Dvoryakovskaya, M.K. Kurdup, D. Vankova, E.L. Semikina, T.V. Radygina

Publikováno v: Voprosy praktičeskoj pediatrii. 15:40-50

Evaluation of the safety profile of vaccines in patients with rheumatic diseases requires an assessment of their impact on disease activity. The effect of antipneumococcal vaccination on the activity of systemic juvenile idiopathic arthritis (sJIA) h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::74d7e93c39512419429f378ff626877e
https://doi.org/10.20953/1817-7646-2020-5-40-50

Zobrazit plný text záznamu

Dynamics of concomitant therapy in children with juvenile idiopathic arthritis treated with etanercept and methotrexate

Autor: A. Fetisova, T. Dvoryakovskaya, Alexandra Chomahidze, Rina Denisova, Alina Alshevskaya, T. Sleptsova, K. Isaeva, Victor Gladkikh, Andrey Moskalev, A. Mamutova, Ekaterina Alexeeva

Publikováno v: Pediatrics and Neonatology, Vol 60, Iss 5, Pp 549-555 (2019)

Background: Both the steroid- and NSAID-sparing effects of biologics in juvenile idiopathic arthritis (JIA) treatment are key aspects of the dynamics of patient’s condition. The proper selection of biologics enables maximum treatment effectiveness

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aea2689c87db3e268eb9b4f0026fc006
https://doi.org/10.1016/j.pedneo.2019.02.003

Zobrazit plný text záznamu

Comparative Efficacy of Adalimumab and Etanercept in Children with Juvenile Idiopathic Arthritis Under 4 Years of Age Depending on Active Uveitis

Autor: T. Dvoryakovskaya, Alexandra Chomahidze, Ekaterina Alexeeva, A. Mamutova, Rina Denisova, K. Isaeva, A. Fetisova, Andrey Moskalev, Alina Alshevskaya, T. Sleptsova

Publikováno v: The Open Rheumatology Journal. 13:1-8

Introduction: In 2011, Etanercept (ETA) was approved for clinical application in patients with Juvenile Idiopathic Arthritis (JIA) older than 2 years of age; Adalimumab (ADA) was approved in 2013. However, the available data for these patients are no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c56fba270a098a6b675a9bbe4fbc264f
https://doi.org/10.2174/1874312901913010001

Zobrazit plný text záznamu

POS1322 DISCONTINUATION OF LONG-TERM ADALIMUMAB TREATMENT IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS-ASSOCIATED UVEITIS

Autor: I. Tsulukiya, E. Alexeeva, T. Dvoryakovskaya, R. Denisova, A. Mamutova, K. Isaeva, A. Chomakhidze, O. Lomakina, A. Fetisova, M. Gautier, K. Chibisova, I. Kriulin, E. Krekhova, M. Botova

Publikováno v: Annals of the Rheumatic Diseases. 81:998.1-998

BackgroundUveitis is the most common extra-articular manifestation of JIA which may lead to sight-threatening ocular complications. Topical corticosteroids are still used in the initial treatment for JIA-associated uveitis. The goal of treatment in t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a2ca34e3208e03ec02aa0226c8935783
https://doi.org/10.1136/annrheumdis-2022-eular.4766

Zobrazit plný text záznamu

AB0372 BIOLOGIC THERAPY IN CHILDREN WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS ACCORDING TO THE FEDERAL REGISTER OF THE RUSSIAN FEDERATION

Autor: M. Botova, E. Alexeeva, T. Dvoryakovskaya, R. Denisova, A. Mamutova, K. Isaeva, A. Chomakhidze, O. Lomakina, A. Fetisova, M. Gautier, K. Chibisova, E. Krekhova, I. Kriulin, I. Tsulukiya, T. Kriulina, N. Kondratyeva

Publikováno v: Annals of the Rheumatic Diseases. 81:1313.1-1313

BackgroundSystemic juvenile idiopathic arthritis (sJIA) is the rarest variant of juvenile idiopathic arthritis, characterized by severe course, frequent exacerbations, the development of life-threatening extra-articular manifestations and complicatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d2aca8a79b4439c15d4b07d550c73de0
https://doi.org/10.1136/annrheumdis-2022-eular.4687

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání